Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Source comparison

Melanotan-2 Before and After: Protocol Comparison

Standard Loading 0.5–1mg daily × 7–14 days 0.5–1mg 2–3× weekly Visible darkening by day 5–7; peak at week 4–6 Nausea 40–60%; flushing 80–90%; erections 30–50%; mole darkening common Fastest visible results but highest adverse event frequency. Most users stop d

This comparison does not assign a generated winner or score.

  • Standard Loading
  • 0.5–1mg daily × 7–14 days
  • 0.5–1mg 2–3× weekly
  • Visible darkening by day 5–7; peak at week 4–6
  • Nausea 40–60%; flushing 80–90%; erections 30–50%; mole darkening common
  • Fastest visible results but highest adverse event frequency. Most users stop during loading phase
  • Low-Dose Protocol
  • 0.25–0.5mg daily × 14–21 days
  • 0.25–0.5mg 2× weekly
  • Visible darkening by day 10–14; peak at week 6–8
  • Nausea 15–25%; flushing 50–60%; erections 10–20%; slower mole darkening
  • Slower tanning but significantly better tolerability. Preferred for Fitzpatrick I/II users
  • Maintenance Only
  • No loading; start 0.5mg 2× weekly
  • Continue 0.5mg 2× weekly indefinitely
  • Visible darkening by day 14–21; gradual deepening over 8–12 weeks
  • Nausea <10%; flushing 20–30%; minimal systemic effects
  • Slowest results; often insufficient for Type I/II skin; lowest adverse event burden
More references

Related material